Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Comment by Fantomatuson Oct 10, 2009 3:26pm
179 Views
Post# 16379861

RE: Est-ce que la qualité de l'informations financ

RE: Est-ce que la qualité de l'informations financ

Salut Immo and Hi everyone!

Bien que nous n'en connaissions pas les tenants et aboutissants, cette entente me rassure
car elle en préfigure d'autres en Europe , aux USA et ailleurs dans le monde. La direction de
Cur manifeste ainsi un sain réalisme.
Il est certes frustrant d'être tenus dans l'ignorance mais pour des considérations stratégiques,
ayant trait a de futures négociations avec d'autres entreprises, il vaut mieux, je crois, être
discrêt et ne pas ouvrir son jeu. Car des sommes d'argent possiblement colossales sont
l'objet de ce genre de tractations.

J'avoue cependant être déçu du peu de publicité dès l'annonce de cette entente.

Normal to be frustrated of not being fully informed with details concerning the agreement
of distribution in UK. But I think that Cur is justified to do so, because there  will be
several agreements of that kind in the coming months, in Europe, in USA and elsewhere.
That's why Cur can't provide us with plenty of information that , if disclosed, could cause
prejudice to its interests during the negociations for possible agreements .

But I confess that I would have liked to see more publicity concerning the agreement in UK.

Fantomatus

Bullboard Posts